Will Downie
The Power List 2021 – Small Molecules
Chief Executive Officer at Vectura
Downie has over 30 years of industry experience and joined Vectura as CEO in November 2019 – helping the company implement its strategic change from an inhaled therapy development company to CDMO in the inhalation field. When asked to comment on the impact of COVID-19 on pharma, he responded, “Often, out of a crisis, great things happen. This is clearly a moment in time where the world has faced one of its biggest challenges, with the pharma industry playing a central role in fighting the pandemic. I truly believe we will look back on COVID-19 as a seminal moment – a time where the impossible was made possible.”
